NO924076L - Antihypertensive midler - Google Patents

Antihypertensive midler

Info

Publication number
NO924076L
NO924076L NO92924076A NO924076A NO924076L NO 924076 L NO924076 L NO 924076L NO 92924076 A NO92924076 A NO 92924076A NO 924076 A NO924076 A NO 924076A NO 924076 L NO924076 L NO 924076L
Authority
NO
Norway
Prior art keywords
lower alkyl
aryl
halogen
optionally substituted
antihypertensive agents
Prior art date
Application number
NO92924076A
Other languages
English (en)
Norwegian (no)
Other versions
NO924076D0 (no
Inventor
Jose Repolles Moliner
Francisco Pubill Coy
Lydia Cabeza Llorente
Carlos Malet Falco
Original Assignee
Lacer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lacer Sa filed Critical Lacer Sa
Publication of NO924076D0 publication Critical patent/NO924076D0/no
Publication of NO924076L publication Critical patent/NO924076L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NO92924076A 1991-02-27 1992-10-21 Antihypertensive midler NO924076L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91102950A EP0500989B1 (en) 1991-02-27 1991-02-27 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents
PCT/EP1992/000400 WO1992015608A1 (en) 1991-02-27 1992-02-26 N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS

Publications (2)

Publication Number Publication Date
NO924076D0 NO924076D0 (no) 1992-10-21
NO924076L true NO924076L (no) 1992-12-21

Family

ID=8206465

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92924076A NO924076L (no) 1991-02-27 1992-10-21 Antihypertensive midler

Country Status (18)

Country Link
US (1) US5432159A (cs)
EP (1) EP0500989B1 (cs)
JP (1) JPH05507295A (cs)
AT (1) ATE174343T1 (cs)
AU (1) AU650954B2 (cs)
BR (1) BR9204779A (cs)
CA (1) CA2081471A1 (cs)
CZ (1) CZ280952B6 (cs)
DE (1) DE69130605T2 (cs)
ES (1) ES2037613B1 (cs)
FI (1) FI924850L (cs)
HU (1) HUT62313A (cs)
NO (1) NO924076L (cs)
PL (1) PL167915B1 (cs)
PT (1) PT100148B (cs)
RO (1) RO111369B1 (cs)
RU (1) RU2098424C1 (cs)
WO (1) WO1992015608A1 (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5825094A (en) * 1993-11-19 1995-06-06 Astra Aktiebolag Novel dipeptide derivatives
JP2000510481A (ja) * 1997-04-04 2000-08-15 ファイザー・プロダクツ・インク ニコチンアミド誘導体
IL136271A (en) * 1998-09-22 2005-06-19 Kaneka Corp Process for the preparation of n<2>-(1(s)-carboxy-3-phenylpropyl)-l-lysyl-l-proline
HUP0400637A2 (hu) 2001-01-31 2004-06-28 Pfizer Products Inc. Nikotinamid-biaril-származékok, amelyek PDE4 izozimek inhibitoraiként alkalmazhatók és ezeket tartalmazó gyógyszerkészítmények
US7250518B2 (en) 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
PL365443A1 (en) 2001-01-31 2005-01-10 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
CA2436544A1 (en) 2001-01-31 2002-08-08 Pfizer Products Inc. Ether derivatives useful as inhibitors of pde4 isozymes
WO2003033471A1 (fr) * 2001-10-17 2003-04-24 Tobishi Pharmaceutical Co.,Ltd Nouveau derive de pyridone et agent therapeutique pour les maladies du systeme circulatoire les contenant
BR0307279A (pt) * 2002-01-29 2004-12-28 Wyeth Corp Métodos para fechar e abrir um semi-canal e uma célula, tecido orgãnico ou órgão, para prevenir ou tratar o estresse de tecido orgãnico ou órgão em um mamìfero, para aumentar a comunicação intracelular da junção com intervalo em uma célula, tecido orgãnico ou órgão, para tratamento de queimaduras, de tromboses, da acidose respitatória e metabólica, e da arritmia focal, para tratar e prevenir o dano de célula e tecido orgãnico resultante de nìveis elevados de glicose no sangue, para tratamento da fibrilação atrial crÈnica e da epilepsia, para criar composto candidatos que modulem a função de semi-canal, para citoproteger tecido orgãnico ou um órgão de um mamìfero em necessidade de tal tratamento, e para prevenir ou tratar o dano da reperfusão em um mamìfero
SI21507A (sl) * 2003-05-16 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo spojin z ace inhibitornim delovanjem
WO2006113199A1 (en) * 2005-04-14 2006-10-26 Merck & Co., Inc. Vla-4 antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU537592B2 (en) * 1979-04-02 1984-07-05 E.R. Squibb & Sons, Inc. Mercaptoacyldipeptides
NZ202232A (en) * 1981-11-06 1985-08-16 Smithkline Beckman Corp N-carboxyalkylproline-containing tripeptides and pharmaceutical compositions
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel

Also Published As

Publication number Publication date
CA2081471A1 (en) 1992-08-28
RU2098424C1 (ru) 1997-12-10
ATE174343T1 (de) 1998-12-15
DE69130605T2 (de) 1999-05-20
WO1992015608A1 (en) 1992-09-17
PL296625A1 (en) 1993-08-09
RO111369B1 (ro) 1996-09-30
JPH05507295A (ja) 1993-10-21
US5432159A (en) 1995-07-11
HUT62313A (en) 1993-04-28
PL167915B1 (pl) 1995-12-30
FI924850A7 (fi) 1992-10-26
HU9203324D0 (en) 1993-01-28
FI924850A0 (fi) 1992-10-26
CZ280952B6 (cs) 1996-05-15
BR9204779A (pt) 1993-08-17
AU650954B2 (en) 1994-07-07
CZ322092A3 (en) 1993-02-17
ES2037613A1 (es) 1993-06-16
PT100148A (pt) 1993-05-31
EP0500989B1 (en) 1998-12-09
PT100148B (pt) 1999-06-30
AU1278392A (en) 1992-10-06
NO924076D0 (no) 1992-10-21
FI924850L (fi) 1992-10-26
ES2037613B1 (es) 1994-03-16
EP0500989A1 (en) 1992-09-02
DE69130605D1 (de) 1999-01-21

Similar Documents

Publication Publication Date Title
DK0590919T3 (da) Terapeutiske midler mod Parkinsons sygdom
NL300086I1 (nl) Pyimidinederivaten en werkwijzen voor de bereidingervan.
NO924076L (no) Antihypertensive midler
DK0787726T3 (da) Ny forbindelse, fremgangsmåde til fremstilling deraf og antitumor-middel
SE8201854L (sv) N-substituerade amino-aminosyror
ZA918893B (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,process for their production and pharmaceutical agents containing these derivatives
NO931166L (no) Piperdinderivater, deres fremstilling og anvendelse for terapi
ZA934997B (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives
PL291129A1 (en) Method of obtaining derivatives of thioalkylcephalosporin
NO302070B1 (no) Pyridinkarboksimidamid-forbindelse og anvendelse av samme
NO307883B1 (no) Antibakterielle pyridonkarboksylsyrederivater
DK0539805T3 (da) Phthalaziner indeholdende en ethergruppe i 1-stilling og fremgangsmåde til fremstilling deraf
ES8607953A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazina
FI830186A0 (fi) Amidderivat
PT1021404E (pt) Derivados de azetidinona para o tratamento de infeccoes pelo hcmv
ATE118207T1 (de) Heterozyklische acylaminodiol-beta-aminosäure- derivate.
ATE92927T1 (de) 1-carboxy-1-vinyloxyiminoaminothiazolcephalosporin-derivate und deren herstellung.
ATE181327T1 (de) Indolderivate
EP0802179A4 (en) DERIVATE SUBSTITUTED AMIDINONAPHTHYLESTER
ES2103675A1 (es) Nuevas piperidinas sustituidas.
DE68910090D1 (de) Verwendung heterozyklischer Amide zur Verhinderung der Tumormetastasierung.
TR199800039T1 (xx) Pirimidin n�kleozit t�revleri.